
🇫🇷 French Tech Wire: Remain Calm...Or Time To Panic?
VCs talk funding famine; US is doing better, but not by much; exits are dead; Revaia closes its €250 fund; and what's the Deel with Rippling?
VCs talk funding famine; US is doing better, but not by much; exits are dead; Revaia closes its €250 fund; and what's the Deel with Rippling?
In Q1 2025, startup funding hit a 7-year low. We talk to 2 prominent VCs to unpack the trend.
Exclusively for Paid Subscribers: The latest filings for new AI-related companies in France, plus AI startups selected for incubators and accelerators.
Startups that raised from March 24 to March 28 also include: DeepIP, Opsima, Neold, Jool, CR-Industry, Luchrome, Anemon, and BuyCo.
Pigment launches AI agents; Aldebaran Robotics folds; Eurazeo bets on infrastructure.
Modern AI workloads were being forced to run on computing architectures designed decades ago. FlexAI wants to create a faster, more flexible system that enables rapid scaling.
VC funding remains in freefall as French startups go hungry; MSInsight offers hope to the future of cancer detection; Yubo offers hope to companies that want to be profitable.
CEO and co-founder Arnaud Dr. Cutivet: “MSI cancer cells are present in 4% of cancers, especially colorectal, stomach, and endometrial cancers. Early detection, particularly in colorectal cancer, means we can use immunotherapy effectively, potentially saving lives.”
Yubo CEO and co-founder Sacha Lazimi: "The goal is to create authentic and meaningful new connections that are not based on followers or likes or comments."
Mistral says no no no IPO; Meta AI invades Europe; Frenchies take a stand against data centers.
Startups that raised from March 1 7 to March 21 also include: Extracadabbra, Spring, Aletiq, Valuesed, Flagcat, Evera, OpenStone, Sharesub, and TheraPPI Bioscience.
Rippling asks: What's the Deel?; Descartes explains its climate risk philosophy; and the battle to protect the startup ecosystem from budget cuts rages on.
Chief Science Officer Kévin Dedieu: "AI represents between 2-5% of our tech investments. Next year, we’re increasing that by 10%, with more resources dedicated to AI and using it for our core models. The cost of AI is relatively low, but its impact is huge.”
What lurks behind 6 mysterious "Stealth" LinkedIn profiles? Our paid subscribers will know.
Spore.bio wages germ-testing warfare; Wandercraft wins a prize for its AI exoskeleton; French publishers tell Meta where to stick its algorithms.
The startup has raised $31.3 million for its light-based AI technology to disrupt centuries-old testing methods across food, pharma, and cosmetics industries.